Albemarle Corporation 2020 Form 10-K Summary
Business context and reporting period
Albemarle is a global specialty chemicals producer serving energy storage, petroleum refining, consumer electronics, construction, automotive, pharmaceuticals, crop protection and other markets. Its reportable segments are Lithium, Bromine Specialties and Catalysts; Fine Chemistry Services is reported in All Other. This Form 10-K covers the fiscal year ended December 31, 2020, including the COVID-19 pandemic period. Approximately 76% of sales were to foreign countries.
Key financial metrics
| Metric | 2020 | 2019 | Change |
|---|---|---|---|
| Net sales | $3.129 billion | $3.589 billion | Down 13% |
| Gross profit | $994.9 million | $1.258 billion | Down 21% |
| Gross margin | 31.8% | 35.0% | Down 3.2 percentage points |
| Operating profit | $505.8 million | $666.1 million | Down 24% |
| Net income attributable to Albemarle | $375.8 million | $533.2 million | Down 30% |
| Diluted EPS | $3.52 | $5.02 | Down 30% |
| Adjusted EBITDA | $818.7 million | $1.037 billion | Down 21% |
| Cash flow from operations | $798.9 million | $719.4 million | Up 11% |
| Capital expenditures | $850.5 million | $851.8 million | Broadly flat |
Segment sales were $1.145 billion in Lithium, $965.0 million in Bromine Specialties, $797.9 million in Catalysts and $221.3 million in All Other. Adjusted EBITDA was $393.1 million, $323.6 million, $130.1 million and $84.8 million, respectively.
At December 31, 2020, cash and cash equivalents were $746.7 million, including $492.8 million held by foreign subsidiaries. Total debt was $3.572 billion, consisting of $804.7 million classified as current and $2.767 billion classified as long-term. Commercial paper outstanding was $325.0 million, with a weighted-average maturity of 16 days. Available borrowing capacity under the commercial paper program and credit agreements was approximately $1.18 billion, subject to covenants and other conditions.
Net property, plant and equipment was $5.355 billion, goodwill was $1.666 billion and total assets were $10.451 billion. Dividends paid to shareholders were $161.8 million; the quarterly dividend was increased to $0.385 per share in the first quarter of 2020.
Material changes versus the prior comparable period
- Sales declined primarily from lower volumes across the reportable segments and $219.3 million of unfavorable pricing, principally in Lithium.
- Lithium sales fell 16% and adjusted EBITDA fell 25%, mainly because of lower contract pricing, modestly lower volumes and weaker equity income from the Windfield joint venture.
- Bromine Specialties sales fell 4% as COVID-19 reduced demand, but pricing and productivity actions largely protected profitability; adjusted EBITDA declined 1%.
- Catalysts sales fell 25% and adjusted EBITDA fell 52%, reflecting lower refinery throughput and fuel demand, travel restrictions, unfavorable FCC pricing and higher freight costs.
- All Other sales increased 34% and adjusted EBITDA increased 71%, driven by higher Fine Chemistry Services volumes.
- Gross margin declined to 31.8% from 35.0%. SG&A declined 19% to $429.8 million because of cost reductions, lower professional fees and lower administrative expenses, partly offset by higher severance.
- Interest and financing expense increased 27% to $73.1 million because of higher debt balances, primarily associated with the Wodgina acquisition and 2020 credit facility borrowings.
- Net income included $40.9 million of after-tax pension and other postretirement actuarial losses, compared with $21.1 million in 2019.
- Operating cash flow increased despite lower earnings, benefiting from lower working-capital outflows, inventory reductions, receivable collections, cost savings and higher dividends from unconsolidated investments.
Guidance, outlook, risks and unusual items
Management expected 2021 Lithium results to be broadly flat year over year, with pricing pressure and higher startup costs offset by modest volume growth and productivity. Bromine Specialties sales and profitability were expected to be modestly higher as pandemic-related demand weakness eased. Catalysts results were expected to be broadly flat, with weaker refining catalyst volumes and a gradual recovery in FCC demand. Management expected continued long-term growth in lithium from electric vehicles, energy storage and declining battery costs, while noting near-term pricing and capacity-startup pressures.
Management forecast 2021 capital expenditures of $850 million to $950 million, primarily for Lithium growth and capacity expansions in Australia, Chile and Silver Peak, Nevada. Kemerton, Australia and La Negra, Chile were expected to be completed by the end of 2021, with sales volumes beginning in 2022. Wodgina production remained idled pending improved market demand. Silver Peak expansion spending of approximately $30 million to $50 million was planned to double production by 2025.
In February 2021, after year-end, Albemarle completed an equity offering of approximately $1.5 billion of gross proceeds, including the exercised underwriters’ option. Proceeds were intended primarily for lithium growth capital expenditures, short-term debt repayment and general corporate purposes.
COVID-19 caused significant demand reductions in Catalysts and Bromine Specialties and created potential supply-chain, customer-demand and covenant-compliance risks. The company amended its credit agreements to increase the maximum net funded debt-to-consolidated EBITDA ratio to 4.50:1 through September 30, 2021, stepping down thereafter. Management stated that it was in compliance at year-end, but a worsening pandemic could require further amendments or create a default risk.
Other key risks include lithium pricing and demand volatility, development of non-lithium battery technologies, idled Wodgina operations, raw-material availability and pricing, foreign exchange, environmental and climate regulation, chemical and mining hazards, cybersecurity, joint-venture execution, impairment of goodwill or mineral assets, and international political and regulatory exposure.
The company continued cooperating with the U.S. Department of Justice, SEC and Dutch Public Prosecutor regarding potential improper payments by third-party sales representatives in the Refining Solutions business. The duration, outcome, penalties and costs were not predictable. Environmental liabilities recorded at year-end were $45.8 million, with management estimating an additional possible exposure of $10 million to $30 million before tax. The company recorded a $7.2 million gain on the fourth-quarter 2020 sale of its SOCC joint-venture interest.
Most important facts for investors to verify
- Whether lithium pricing stabilizes and whether EV and energy-storage demand supports the planned capacity expansions.
- The timing, cost, commissioning and customer qualification of the Kemerton and La Negra projects.
- When Wodgina production can restart and whether the investment generates an acceptable return while idled.
- Refinery catalyst demand recovery, including the timing of FCC and HPC volume normalization.
- Liquidity after the $1.5 billion equity offering, the $804.7 million of 2021 debt maturities and planned 2021 capital expenditures.
- Compliance with amended debt covenants and refinancing plans for commercial paper and other near-term maturities.
- The outcome and potential financial impact of the DOJ, SEC and Dutch Public Prosecutor investigations.
- Changes in environmental remediation, asset-retirement and tax liabilities, including the possible $10 million to $30 million incremental environmental exposure.
- The carrying values and impairment sensitivity of $1.666 billion of goodwill, particularly the $189.8 million Refining Solutions balance, and lithium-related mineral assets.